Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in ELVN held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 10.0M | $508.8M | +46.8% | 14.033% | 0.02% |
| 2 | ORBIMED ADVISORS LLC | 6.8M | $343.9M | -14.9% | 9.486% | 6.37% |
| 3 | Polar Capital Holdings Plc | 6.4M | $326.4M | +26.9% | 9.002% | 0.77% |
| 4 | BlackRock, Inc. | 4.4M | $221.3M | +18.3% | 6.103% | 0.00% |
| 5 | Vestal Point Capital, LP | 4.0M | $203.0M | +23.1% | 5.599% | 4.74% |
| 6 | Commodore Capital LP | 3.3M | $166.2M | 0.0% | 4.584% | 9.90% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 2.6M | $130.4M | +18.5% | 3.596% | 0.00% |
| 8 | CITADEL ADVISORS LLC | 2.1M | $108.7M | +14.4% | 2.997% | 0.01% |
| 9 | Fairmount Funds Management LLC | 1.9M | $94.2M | 0.0% | 2.598% | 6.22% |
| 10 | Siren, L.L.C. | 1.8M | $90.1M | +137.8% | 2.484% | 1.82% |
| 11 | Bellevue Group AG | 1.5M | $75.6M | -35.8% | 2.086% | 1.59% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $71.4M | +32.0% | 1.970% | 0.00% |
| 13 | First Light Asset Management, LLC | 1.4M | $69.1M | +574.1% | 1.905% | 4.20% |
| 14 | STATE STREET CORP | 1.2M | $61.6M | +11.2% | 1.699% | 0.00% |
| 15 | Pictet Asset Management Holding SA | 1.2M | $59.0M | +25.0% | 1.626% | 0.06% |
| 16 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.1M | $55.0M | — | 1.516% | 0.08% |
| 17 | Novo Holdings A/S | 1.0M | $50.8M | -21.9% | 1.400% | 2.95% |
| 18 | First Turn Management, LLC | 954K | $48.4M | +53.0% | 1.336% | 5.18% |
| 19 | SAMLYN CAPITAL, LLC | 913K | $46.3M | — | 1.278% | 0.75% |
| 20 | BAKER BROS. ADVISORS LP | 905K | $45.9M | 0.0% | 1.267% | 0.23% |
| 21 | Candriam S.C.A. | 906K | $45.9M | +52.4% | 1.268% | 0.21% |
| 22 | Tri Locum Partners LP | 867K | $44.0M | — | 1.213% | 5.41% |
| 23 | ALLIANCEBERNSTEIN L.P. | 896K | $35.1M | +16.1% | 1.255% | 0.01% |
| 24 | DIMENSIONAL FUND ADVISORS LP | 671K | $34.1M | -1.5% | 0.940% | 0.01% |
| 25 | BALYASNY ASSET MANAGEMENT L.P. | 607K | $30.8M | +95.9% | 0.850% | 0.04% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in ELVN — a direct measure of their conviction.
Filings activity in ELVN during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 211 | +23% | 112.42% | +4.82 pp | $3.88B | +57% |
| Q1 2026 | 171 | +34% | 107.60% | +0.06 pp | $2.48B | +159% |
| Q4 2025 | 128 | 4.5% | 107.54% | +5.35 pp | $959M | 19% |
| Q3 2025 | 134 | +5.5% | 102.19% | 0.71 pp | $1.18B | +1.2% |
| Q2 2025 | 127 | +2.4% | 102.90% | +0.93 pp | $1.17B | +22% |
| Q1 2025 | 124 | +9.7% | 101.97% | +1.66 pp | $955M | 10% |
| Q4 2024 | 113 | +11% | 100.31% | +0.62 pp | $1.07B | 8.3% |
| Q3 2024 | 102 | — | 99.69% | — | $1.16B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying ELVN stock.
Based on Q2 2026 13F filings, institutional ownership of Enliven Therapeutics, Inc. stands at 112.4%, held across 211 reporting institutions.
FMR LLC is the largest reported institutional holder of ELVN, with approximately 10,025,017 shares worth $0.51B as of Q2 2026.
Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of ELVN, including CITADEL ADVISORS LLC.
Our composite Smart Money Score for ELVN is 71 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
57 institutions opened new positions in ELVN during Q2 2026, while 17 fully exited. 122 added to existing positions and 26 trimmed.
ELVN institutional ownership rose by 4.82 percentage points quarter-over-quarter, with a net change of +40 holders.
The top 10 institutions account for 56.5% of all reported 13F value in ELVN, and the top 25 account for 76.4%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Enliven Therapeutics, Inc. (ELVN) Institutional Ownership